Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Omega Therapeutics, Inc. (OMGA) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Omega Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1850838.
Total stock buying since 2021: $76,246,418.
Total stock sales since 2021: $280,000.
Total stock option exercises since 2021: $5,989.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 3,323,310 | $19,208,731 | 25,000 | $200,000 | 0 | $0 |
| 2022 | 0 | $0 | 10,000 | $80,000 | 11,300 | $5,989 |
| 2021 | 3,358,961 | $57,037,687 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-06 | 0 | $0 | 5,000 | $40,000 | 0 | $0 |
| 2023-05 | 0 | $0 | 5,000 | $40,000 | 0 | $0 |
| 2023-04 | 0 | $0 | 5,000 | $40,000 | 0 | $0 |
| 2023-03 | 0 | $0 | 10,000 | $80,000 | 0 | $0 |
| 2023-02 | 3,323,310 | $19,208,731 | 0 | $0 | 0 | $0 |
| 2022-09 | 0 | $0 | 10,000 | $80,000 | 0 | $0 |
| 2022-02 | 0 | $0 | 0 | $0 | 11,300 | $5,989 |
| 2021-08 | 3,283,961 | $55,827,337 | 0 | $0 | 0 | $0 |
| 2021-07 | 75,000 | $1,210,350 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-02 | Young Richard A (Director) | Sale | 5,000 | 8.00 | 40,000 |
| 2023-05-01 | Young Richard A (Director) | Sale | 5,000 | 8.00 | 40,000 |
| 2023-04-06 | Young Richard A (Director) | Sale | 5,000 | 8.00 | 40,000 |
| 2023-03-17 | Young Richard A (Director) | Sale | 10,000 | 8.00 | 80,000 |
| 2023-02-27 | Afeyan Noubar (Director) | Buy | 3,323,310 | 5.78 | 19,208,731 |
| 2022-09-14 | Young Richard A (Director) | Sale | 10,000 | 8.00 | 80,000 |
| 2022-02-01 | Karande Mahesh (President and CEO) | Option Ex | 11,300 | .53 | 5,989 |
| 2021-08-03 | Sawhney Roger (Chief Financial Officer) | Buy | 2,941 | 17.00 | 49,997 |
| 2021-08-03 | Flagship Venturelabs V Llc (10% Owner) | Buy | 1,176,469 | 17.00 | 19,999,973 |
| 2021-08-03 | Invus Public Equities Advisors, Llc (10% Owner) | Buy | 875,000 | 17.00 | 14,875,000 |
| 2021-08-03 | Afeyan Noubar (Director) | Buy | 1,176,469 | 17.00 | 19,999,973 |
| 2021-08-03 | Berry David A (Director) | Buy | 53,082 | 17.00 | 902,394 |
| 2021-07-30 | Invus Public Equities Advisors, Llc (10% Owner) | Buy | 75,000 | 16.14 | 1,210,350 |
Insider trading activities including stock purchases, stock sales, and option exercises of OMGA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Omega Therapeutics, Inc. (symbol OMGA, CIK number 1850838) see the Securities and Exchange Commission (SEC) website.